Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N0ZK
|
|||
| Former ID |
DNC004099
|
|||
| Drug Name |
(4S)-4-ammoniopentanoate
|
|||
| Synonyms |
(S)-4-Aminovaleric acid; (S)-4-Aminopentanoic acid; (4S)-4-aminopentanoic acid; 4S-aminopentanoic acid; UNII-G98ZJ0KD1D; G98ZJ0KD1D; 1558-59-4; Pentanoic acid, 4-amino-, (S)-; (4S)-4-ammoniopentanoate; 4-Aminovaleric acid, (S)-; AC1NSNZ5; SCHEMBL288484; CHEMBL284327; ZINC3581353; LMFA01100022; Pentanoic acid, 4-amino-, (4S)-; (2E,4S)-4-aminopent-2-enoic acid; AKOS027321168; UNII-CDM626IVRT component ABSTXSZPGHDTAF-BYPYZUCNSA-N
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C5H11NO2
|
|||
| Canonical SMILES |
CC(CCC(=O)O)N
|
|||
| InChI |
1S/C5H11NO2/c1-4(6)2-3-5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1
|
|||
| InChIKey |
ABSTXSZPGHDTAF-BYPYZUCNSA-N
|
|||
| CAS Number |
CAS 1558-59-4
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | GABA(A) receptor alpha-1 (GABRA1) | Target Info | Inhibitor | [1] |
| GABA(A) receptor alpha-2 (GABRA2) | Target Info | Inhibitor | [1] | |
| GABA(A) receptor alpha-3 (GABRA3) | Target Info | Inhibitor | [1] | |
| GABA(A) receptor alpha-5 (GABRA5) | Target Info | Inhibitor | [1] | |
| GABA(A) receptor beta-2 (GABRB2) | Target Info | Inhibitor | [1] | |
| GABA(A) receptor gamma-2 (GABRG2) | Target Info | Inhibitor | [1] | |
| Gamma-aminobutyric acid receptor (GAR) | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Retrograde endocannabinoid signaling | ||||
| Serotonergic synapse | ||||
| GABAergic synapse | ||||
| Morphine addiction | ||||
| Nicotine addiction | ||||
| Reactome | Ligand-gated ion channel transport | |||
| GABA A receptor activation | ||||
| WikiPathways | Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | |||
| Iron uptake and transport | ||||
| SIDS Susceptibility Pathways | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | gamma-Aminobutyric acid agonists, antagonists, and uptake inhibitors. Design and therapeutic aspects. J Med Chem. 1981 Dec;24(12):1377-83. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.